MSK Wesrchester is a clinical research site located in Harrison, New York, United States 10604.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
MSK Wesrchester has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Urothelial Carcinoma.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MSK Wesrchester has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MSK Wesrchester has 1 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma.
MSK Wesrchester has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.